This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Digital transformation has much to offer lifesciences as well as healthcare — and the synergies between the two can further optimize the power of digital health, clinical trials and patient outcomes.
European lifesciences venture capital firm Forbion has raised €1.35bn ($1.47bn) across its two new funds. The Forbion Growth Opportunities Fund II provides support to the expansion of late-stage lifesciences companies. The latest fundraising brings the total funds managed by the company to €3bn ($3.28bn).
Federation of Asian Biotech Associations’ (FABA) LifeSciences Innovation Cluster is now working to strengthen the global partnerships to propel an ecosystem for novel biologics and diagnostics.
Biotechnology company Tiziana LifeSciences has revealed plans to assess intranasal foralumab as a potential treatment for long Covid. Tiziana LifeSciences chief medical officer Matthew Davis said: “We anticipate entering into a Phase 2a placebo-controlled clinical trial upon successful feedback from the FDA.
XtalPi has entered a strategic partnership with CK LifeSciences for artificial intelligence (AI)-driven tumour vaccine research and development (R&D). The post XtalPi and CK LifeSciences to develop AI-driven tumour vaccine R&D platform appeared first on Pharmaceutical Technology.
The Indian lifesciences sector is making strides by integrating quantum computing, artificial intelligence (AI), machine learning (ML), advanced analytics, big data, internet of things (IoT) and blockchain into their research and development efforts.
As the Union Budget approaches, the lifesciences sector anticipates substantial support to enhance innovation and investment in the development of new chemical entities (NCEs) and new biological entities (NBEs). The lifesciences sector in India has shown remarkable resilience […]
The new firm intends to carefully select its startups and fund them for the long haul. “We're not a company formation factory,” said Aaron Kantoff, the firm’s co-founder.
The fund, Third Rock’s sixth, comes amid a significant downturn in the biotech stock market, which has raised questions about the viability of young drug startups.
Australia is fast becoming the place to be for innovative lifesciences companies, as proved by Melbourne’s latest FDI wins from the likes of BioNTech and Moderna.
Research from Everest Group shows how lifesciences leaders are investing in process mining to speed time-to-market, improve regulatory compliance and drive innovation.
This week, were celebrating a significant milestone: the release of our 200th episode of the Xtalks LifeScience Podcast ! We’re excited to continue our journey by bringing you more in-depth conversations with industry leaders, highlighting the innovations and trends that shape the future of lifesciences.
Early study data from Wave LifeSciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start.
As an authority in radiation oncology, Dr. Khuntia joining the board of directors validates BNCT and the work TAE LifeSciences is doing to make it a mainstay of modern cancer care IRVINE, Calif.- FASTRO, to its esteemed Board of Directors.
Listen to the podcast interview with Manny Belabe from ArisGlobal as he discusses The LifeSciences Generative AI Council and its role in creating a sustainable technological future. Gain insights into the future of AI in lifesciences.
The lifesciences sector in Ireland is booming thanks to nurturing talent and fostering innovation. Companies like Eli Lilly and Regeneron have major operations driving excellence.
We are deeply honored to be recognized in Everest Group’s PEAK Matrix® for LifeSciences CTMS solutions,” said Dinesh Kashyap, CEO and Founder of Cloudbyz. Our mission is to enable faster, more efficient trials, ultimately supporting the delivery of life-saving therapies.”
The veteran investors see the marriage of tech and lifesciences as the “largest opportunity in venture today,” said co-founder and former Lux Capital general partner Adam Goulburn.
Wave LifeSciences Ltd patent reveals a groundbreaking method for synthesizing high-purity oligonucleotides with increased yields. Learn more about this innovative process now!
Explore the vital partnerships and people involved in shaping Labour's policies on the NHS, healthcare, and lifesciences during the general election. Learn more about the key areas of focus and priorities.
Explore how the recent and upcoming elections may impact the field of lifesciences and medical technology. Stay informed about the intersection of politics and health advancements.
Denali’s medicine and a similar one from Calico LifeSciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.
SK LifeScience Leverages Smart, Efficient Solutions Across its Engaged Industry-Leading Sales Team Mike.Hammerton Thu, 11/07/2024 - 08:00 Bookmark this
Discover how AI-powered analytics are revolutionising lifesciences marketing. Learn how to leverage these cutting-edge technologies to drive insights and success in the industry.
Completion of the buyout eases concerns the arrangement might be held up by the FTC, which has signaled it will step up scrutiny of lifesciences deals.
The lifesciences investor spoke with BioPharma Dive about emerging lifesciences markets around the globe and why the firm invests in first-time biotech founders.
Stay ahead of the game by keeping an eye on these six lifesciences real estate trends to watch in 2025. From AI integration to collaborative incubator spaces, the industry is evolving rapidly.
Discover the latest advancements in lifesciences R&D and quality at the Veeva R&D Quality Summit at the Marriott Auditorium Hotel in Madrid. Join industry leaders as they discuss the importance of a single source of truth.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content